Eris Lifesciences Ltd. - Research Center
540596 ERIS Group (A) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
341.30 |
324.41 |
409.71 |
411.29 |
314.58 |
Operating profit |
79.39 |
74.43 |
144.49 |
155.50 |
111.49 |
Interest |
28.89 |
15.14 |
6.55 |
6.84 |
2.96 |
Gross profit |
70.89 |
62.73 |
144.92 |
152.69 |
112.79 |
EPS (Rs) |
2.90 |
2.33 |
8.66 |
8.14 |
6.46 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
20.39 |
3.43 |
6.98 |
4.03 |
4.26 |
Stock adjustment |
10.40 |
4.65 |
-2.95 |
-25.25 |
-6.06 |
Raw material |
17.74 |
23.75 |
28.64 |
26.17 |
25.07 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
79.52 |
80.69 |
81.10 |
90.36 |
60.63 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
154.25 |
140.90 |
158.44 |
164.50 |
123.45 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
29.14 |
28.08 |
25.00 |
20.16 |
17.28 |
Taxation |
2.24 |
2.99 |
2.11 |
21.78 |
7.67 |
Net profit / loss |
39.51 |
31.66 |
117.81 |
110.74 |
87.84 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
13.60 |
13.60 |
13.60 |
13.60 |
13.60 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
23.26 |
22.94 |
35.27 |
37.81 |
35.44 |
GPM (%) |
19.60 |
19.13 |
34.78 |
36.76 |
35.38 |
NPM (%) |
10.92 |
9.66 |
28.27 |
26.66 |
27.55 |